Carol Caesar

2.6k total citations · 1 hit paper
14 papers, 2.1k citations indexed

About

Carol Caesar is a scholar working on Oncology, Molecular Biology and Physiology. According to data from OpenAlex, Carol Caesar has authored 14 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 13 papers in Molecular Biology and 3 papers in Physiology. Recurrent topics in Carol Caesar's work include Lymphatic System and Diseases (14 papers), Angiogenesis and VEGF in Cancer (13 papers) and Sympathectomy and Hyperhidrosis Treatments (3 papers). Carol Caesar is often cited by papers focused on Lymphatic System and Diseases (14 papers), Angiogenesis and VEGF in Cancer (13 papers) and Sympathectomy and Hyperhidrosis Treatments (3 papers). Carol Caesar collaborates with scholars based in Australia, Finland and New Zealand. Carol Caesar's co-authors include Steven A. Stacker, Marc G. Achen, Megan E. Baldwin, Remko Prevo, David G. Jackson, Hajime Kubo, Shin‐Ichi Nishikawa, Richard A. Williams, Angela A. Vitali and Sally Roufail and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Medicine.

In The Last Decade

Carol Caesar

14 papers receiving 2.0k citations

Hit Papers

VEGF-D promotes the metastatic spread of tumor cells via ... 2001 2026 2009 2017 2001 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Carol Caesar Australia 12 1.5k 1.4k 335 267 263 14 2.1k
Sally Roufail Australia 18 1.3k 0.9× 1.2k 0.8× 306 0.9× 295 1.1× 189 0.7× 25 1.8k
Angela A. Vitali Australia 9 1.1k 0.8× 1.3k 0.9× 231 0.7× 165 0.6× 220 0.8× 12 1.8k
Thomas Hawighorst Germany 13 1.7k 1.1× 1.7k 1.2× 401 1.2× 259 1.0× 467 1.8× 15 2.6k
Lucia Riccardi United States 9 1.4k 0.9× 1.7k 1.2× 328 1.0× 197 0.7× 509 1.9× 10 2.4k
Lothar C. Dieterich Switzerland 27 1.2k 0.8× 945 0.7× 214 0.6× 189 0.7× 257 1.0× 49 2.0k
Hanseul Yang United States 17 787 0.5× 1.1k 0.8× 216 0.6× 143 0.5× 301 1.1× 21 2.2k
Yasuhiro Yoshimatsu Japan 20 630 0.4× 1.1k 0.8× 172 0.5× 127 0.5× 237 0.9× 32 1.7k
Barry Grimes United States 14 754 0.5× 1.5k 1.0× 158 0.5× 199 0.7× 309 1.2× 17 2.5k
Gerhard Raab United States 14 619 0.4× 982 0.7× 208 0.6× 89 0.3× 294 1.1× 17 1.9k
Simona Podgrabinska United States 9 957 0.6× 633 0.4× 211 0.6× 188 0.7× 111 0.4× 11 1.3k

Countries citing papers authored by Carol Caesar

Since Specialization
Citations

This map shows the geographic impact of Carol Caesar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carol Caesar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carol Caesar more than expected).

Fields of papers citing papers by Carol Caesar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carol Caesar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carol Caesar. The network helps show where Carol Caesar may publish in the future.

Co-authorship network of co-authors of Carol Caesar

This figure shows the co-authorship network connecting the top 25 collaborators of Carol Caesar. A scholar is included among the top collaborators of Carol Caesar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carol Caesar. Carol Caesar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Karnezis, Tara, Rae H. Farnsworth, Nicole C. Harris, et al.. (2019). CCL27/CCL28–CCR10 Chemokine Signaling Mediates Migration of Lymphatic Endothelial Cells. Cancer Research. 79(7). 1558–1572. 39 indexed citations
2.
Williams, Steven P., Carol Caesar, Cameron J. Nowell, et al.. (2017). A Three-Dimensional Lymphatic Endothelial Cell Tube Formation Assay to Identify Novel Kinases Involved in Lymphatic Vessel Remodeling. Assay and Drug Development Technologies. 15(1). 30–43. 3 indexed citations
3.
Stacker, Steven A., Michael M. Halford, Sally Roufail, Carol Caesar, & Marc G. Achen. (2016). A Simple Bioassay for the Evaluation of Vascular Endothelial Growth Factors. Journal of Visualized Experiments. 6 indexed citations
4.
Matsumoto, Masataka, Sally Roufail, Carol Caesar, et al.. (2013). Signaling for lymphangiogenesis via VEGFR-3 is required for the early events of metastasis. Clinical & Experimental Metastasis. 30(6). 819–832. 34 indexed citations
5.
Shayan, Ramin, Tara Karnezis, Carol Caesar, et al.. (2012). Tumor location and nature of lymphatic vessels are key determinants of cancer metastasis. Clinical & Experimental Metastasis. 30(3). 345–356. 26 indexed citations
6.
Karnezis, Tara, Ramin Shayan, Carol Caesar, et al.. (2012). VEGF-D Promotes Tumor Metastasis by Regulating Prostaglandins Produced by the Collecting Lymphatic Endothelium. Cancer Cell. 21(2). 181–195. 224 indexed citations
7.
Stacker, Steven A., Rae H. Farnsworth, Tara Karnezis, et al.. (2006). Molecular Pathways for Lymphangiogenesis and their Role in Human Disease. Novartis Foundation symposium. 281. 38–49. 16 indexed citations
8.
Wise, Lyn M., Norihito Ueda, Nicola H. Dryden, et al.. (2003). Viral Vascular Endothelial Growth Factors Vary Extensively in Amino Acid Sequence, Receptor-binding Specificities, and the Ability to Induce Vascular Permeability yet Are Uniformly Active Mitogens. Journal of Biological Chemistry. 278(39). 38004–38014. 60 indexed citations
9.
Stacker, Steven A., Carol Caesar, Megan E. Baldwin, et al.. (2001). VEGF-D promotes the metastatic spread of tumor cells via the lymphatics. Nature Medicine. 7(2). 186–191. 993 indexed citations breakdown →
10.
Stacker, Steven A., Carol Caesar, Alberto Vitali, et al.. (2000). The 3T3-L1 Fibroblast to Adipocyte Conversion is Accompanied by Increased Expression of Angiopoietin-1, A Ligand for Tie2. Growth Factors. 18(3). 177–191. 14 indexed citations
11.
Achen, Marc G., Sally Roufail, Teresa Domagała, et al.. (2000). Monoclonal antibodies to vascular endothelial growth factor‐D block its interactions with both VEGF receptor‐2 and VEGF receptor‐3. European Journal of Biochemistry. 267(9). 2505–2515. 94 indexed citations
12.
Stacker, Steven A., Kaye L. Stenvers, Carol Caesar, et al.. (1999). Biosynthesis of Vascular Endothelial Growth Factor-D Involves Proteolytic Processing Which Generates Non-covalent Homodimers. Journal of Biological Chemistry. 274(45). 32127–32136. 269 indexed citations
13.
Stacker, Steven A., Angela A. Vitali, Carol Caesar, et al.. (1999). A Mutant Form of Vascular Endothelial Growth Factor (VEGF) That Lacks VEGF Receptor-2 Activation Retains the Ability to Induce Vascular Permeability. Journal of Biological Chemistry. 274(49). 34884–34892. 93 indexed citations
14.
Wise, Lyn M., Tanja Veikkola, Andrew A. Mercer, et al.. (1999). Vascular endothelial growth factor (VEGF)-like protein from orf virus NZ2 binds to VEGFR2 and neuropilin-1. Proceedings of the National Academy of Sciences. 96(6). 3071–3076. 218 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026